Unique, practical knowledge for nurses responsible for daily management of patients with cardiovascular disease, diabetes and related conditions.

Sacubitril/valsartan in primary care: the practice nurse’s role

Sacubitril/valsartan in primary care: the practice nurse’s role

Publication date: Friday, 21 October 2016
Contributor(s): Jacqueline Hall

Many patients with heart failure rely on practice nurses to monitor their care. A multidisciplinary team (MDT) integrated community approach has been endorsed by NICE guidelines when delivering HF care. This article provides practice nurses with the information they need to understand the condition, current treatment guidelines, and the new treatment – sacubitril/valsartan, the first-in-class angiotensin receptor-neprilysin inhibitor.

Sponsorship information:
This sponsored supplement was initiated and funded by Novartis. Novartis reviewed the supplement for technical accuracy and suitability within the ABPI Code of Practice. Final editorial control rests with the authors and editors.
Topics covered:
Category: Editorial
Edition: Volume 13, Number 1, Oct-Nov-Dec 2016
Contributor(s): Jacqueline Hall

Article search and filter